Home LiteratureArticle Details
PMID: 1277711 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.

Clinical pharmacology and therapeutics ·Vol. 19 ·No. 5 Pt 1 ·1976-05-00 ·Pages 552-8

Yacobi A, Udall JA, Levy G

Abstract

The serum protein binding and elimination kinetics of warfarin were determined in 31 patients with cardiovascular disease who were taking warfarin regularly. The free fraction of warfarin in the serum ranged from 0.00436 to 0.0189, indicating 98.11% to 99.56% protein binding. There was no apparent relationship between the extent of protein binding of warfarin and the concentration of albumin or total protein in the serum. The estimated total body clearance of warfarin in the patients ranged from 1.16 to 4.35ml/hr/kg of body weight and correlated significantly with the free fraction of warfarin in serum. This correlation has been predicted on theoretical grounds and shows that serum protein binding is a major determinant of the elimination kinetics of warfarin in man and an important cause of interindividual variations in its body clearance. The interindividual variation of free warfarin concentrations in the serum of patients with similar prothrombin times was somewhat smaller than the variations in total serum-warfarin concentrations and in the daily dose of warfarin. There was no correlation between prothrombin time and the concentration of free warfarin in serum, indicating that variables other than protein binding also affect the anticoagulant response of patients.

MeSH Terms
Adult Aged Anticoagulants/pharmacology Cardiovascular Diseases/drug therapy Female Humans Male Middle Aged Protein Binding Prothrombin Time Warfarin/metabolism,pharmacology,therapeutic use
Chemicals
Anticoagulants Warfarin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Yacobi A
Udall J A
Levy G
Article Info
Journal
Clinical pharmacology and therapeutics
Abbr.
Clin Pharmacol Ther
ISSN
0009-9236
Published
1976-05-00
Pages
552-8
Language
English
Region
United States
NLM ID
0372741
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com